South Korea News

Finance·News·South Korea News·Stock Market

KOSPI breaks 5,800 on Korea Exchange — what to watch for South Korean stocks next week

South Korea’s KOSPI closed at a record 5,808.53 on Friday, up 2.31%, driven by institutional buying and gains in chip stocks. The KOSDAQ fell 0.58% to 1,154.00. BlackRock disclosed a 5% stake in SK hynix. The Bank of Korea’s next policy meeting is set for Feb. 26.

February 21, 2026

Aroa Biosurgery Advances in US$3 Billion Woundcare Market with Innovative Myriad Device
May 26, 2026, 4:20 PM EDT. Aroa Biosurgery (ASX:ARX) is expanding in the US woundcare market, valued at over US$3 billion, with its flagship Myriad product. The company, based in Auckland, leverages unique sheep-derived biomaterials to improve patient outcomes while lowering hospital costs. Despite stiff competition and reimbursement challenges, Aroa has reported two consecutive years of positive earnings. It focuses on robust clinical evidence, including large-scale, randomized studies, to prove the efficacy of its devices in treating complex wounds and diabetic foot ulcers. CEO Brian Ward highlights the economic benefit of reducing repeat procedures, aligning clinical success with hospital budget restraints. Aroa's diversified portfolio also includes Endoform and Symphony, while it licenses TELA Bio for additional surgical applications.